JNJ

227.55

+1.33%↑

ISRG

521.53

-0.83%↓

ABT

106.07

-1.49%↓

MDT

100.69

+0.19%↑

133.98

-1.27%↓

JNJ

227.55

+1.33%↑

ISRG

521.53

-0.83%↓

ABT

106.07

-1.49%↓

MDT

100.69

+0.19%↑

133.98

-1.27%↓

JNJ

227.55

+1.33%↑

ISRG

521.53

-0.83%↓

ABT

106.07

-1.49%↓

MDT

100.69

+0.19%↑

133.98

-1.27%↓

JNJ

227.55

+1.33%↑

ISRG

521.53

-0.83%↓

ABT

106.07

-1.49%↓

MDT

100.69

+0.19%↑

133.98

-1.27%↓

JNJ

227.55

+1.33%↑

ISRG

521.53

-0.83%↓

ABT

106.07

-1.49%↓

MDT

100.69

+0.19%↑

133.98

-1.27%↓

Inicio・Lista de Acciones・Avita Therapeutics Inc

Avita Therapeutics Inc

Abierto

4.43 -1.56

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

4.38

Máximo

4.52

Métricas clave
By Trading Economics
Ingresos	-3.3M -13M
Ventas	-1.4M 17M
Margen de beneficios	-77.289
Empleados	260
EBITDA	-3.2M -11M

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 Meses	-1.53% downside

Dividendos
By Dow Jones
Próximas Ganancias	12 feb 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	-2.1M 119M
Apertura anterior	5.99
Cierre anterior	4.43

Puntuación técnica

By Trading Central

Confianza

Very Strong Bearish Evidence

8.83 / 9.77 Soporte y Resistencia

Avita Therapeutics Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

27 ene 2026, 23:07 UTC

Ganancias

Texas Instruments Says Data Centers, Industrial Recovery Driving Growth into 1Q -- Update

27 ene 2026, 21:27 UTC

Ganancias

Texas Instruments 4Q Sales Rise, Profit Falls

27 ene 2026, 23:55 UTC

Charlas de Mercado

Yen Weakens Slightly on Possible Technical Correction -- Market Talk

27 ene 2026, 23:47 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

27 ene 2026, 23:47 UTC

Charlas de Mercado

Nikkei May Decline Amid Caution Over Earnings -- Market Talk

27 ene 2026, 23:39 UTC

Charlas de Mercado

Gold Falls on Likely Technical Correction, Possible Profit-Taking -- Market Talk

27 ene 2026, 23:20 UTC

Ganancias

SK Innovation: Asset-Impairment Losses Weighed on Earnings

27 ene 2026, 23:20 UTC

Ganancias

SK Innovation: Industry Downturn, Narrower Profit Margins Weighed on Earnings

27 ene 2026, 23:19 UTC

Ganancias

SK Innovation Posts Net Loss for Second Consecutive Year

27 ene 2026, 23:19 UTC

Ganancias

SK Innovation 2025 Loss KRW5.406T Vs. Loss KRW2.372T >096770.SE

27 ene 2026, 23:18 UTC

Ganancias

SK Innovation 2025 Oper Pft KRW448.07B Vs. Pft KRW356.07B >096770.SE

27 ene 2026, 23:18 UTC

Ganancias

SK Innovation 2025 Rev KRW80.296T Vs. KRW74.243T >096770.SE

27 ene 2026, 23:11 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

27 ene 2026, 23:11 UTC

Charlas de Mercado

Alkane Resources Bull Positive on Outlook in Red-Hot Gold Market -- Market Talk

27 ene 2026, 23:07 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

Freightways's Australian M&A Adds Ballast to Bull's View -- Market Talk

27 ene 2026, 22:17 UTC

Charlas de Mercado

U.S. Dollar Slips Following Trump Comments -- Market Talk

27 ene 2026, 22:06 UTC

Ganancias

Boeing's Stepped-Up Plane Deliveries Lift Sales -- Update

27 ene 2026, 21:51 UTC

Ganancias

Texas Instruments Stock Jumps on Strong Outlook -- Barrons.com

27 ene 2026, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

27 ene 2026, 21:43 UTC

Ganancias

RTX Stock Jumps After Earnings. It Has 'Great Momentum,' Says CEO. -- Barrons.com

27 ene 2026, 21:41 UTC

Ganancias

GM Lost Billions on EVs, Still Beat Wall Street's Expectations -- 5th Update

27 ene 2026, 21:38 UTC

Ganancias

These Stocks Are Today's Movers: UnitedHealth, Humana, Micron, Corning, CoreWeave, UPS, GM, and More -- Barrons.com

27 ene 2026, 21:32 UTC

Ganancias

Ampol: Modest Profit From F&I International in 2025

27 ene 2026, 21:32 UTC

Ganancias

Ampol: F&I Australia Ebit Up by High Single Digit Percent in 2025

27 ene 2026, 21:31 UTC

Ganancias

Ampol: New Zealand Ebit in 2025 In Line With Prior Year

27 ene 2026, 21:31 UTC

Ganancias

Ampol: Australia Convenience Retail Ebit Up Mid-Single Digit Percent in 2025

27 ene 2026, 21:30 UTC

Ganancias

Ampol 4Q Lytton Refinery Production 1.56 Billion Liters

27 ene 2026, 21:29 UTC

Ganancias

Ampol FY Unaudited Replacement-Cost Ebitda A$1.44 Billion

27 ene 2026, 21:29 UTC

Ganancias

Ampol FY Unaudited Replacement-Cost Operating Profit A$945 Million

27 ene 2026, 21:28 UTC

Ganancias

Ampol 4Q Lytton Refiner Margin US$15.14/Bbl

Comparación entre iguales

Cambio de precio

Avita Therapeutics Inc previsión

Precio Objetivo

By TipRanks

-1.53% descenso

Estimación a 12 Meses

Media 4.5 USD -1.53%

Máximo 5.5 USD

Mínimo 3.5 USD

De acuerdo con 3 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Avita Therapeutics Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

3 ratings

Comprar

Mantener

Vender

De acuerdo con 3 analistas que ofrecen calificaciones bursátiles a para Avita Therapeutics Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

8.83 / 9.77Soporte y Resistencia

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Avita Therapeutics Inc

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.